Works about EZETIMIBE
Results: 523
Cost effective prescribing in cardiovascular disease.
- Published in:
- Practice Nursing, 2012, v. 23, n. 10, p. 488, doi. 10.12968/pnur.2012.23.10.488
- By:
- Publication type:
- Article
Coenzyme Q10 Ameliorates the Reduction in GLUT4 Transporter Expression Induced by Simvastatin in 3T3-L1 Adipocytes.
- Published in:
- Metabolic Syndrome & Related Disorders, 2013, v. 11, n. 4, p. 251, doi. 10.1089/met.2012.0177
- By:
- Publication type:
- Article
Effects of Coadministered Ezetimibe Plus Fenofibrate in Mixed Dyslipidemic Patients with Metabolic Syndrome.
- Published in:
- Metabolic Syndrome & Related Disorders, 2011, v. 9, n. 2, p. 135, doi. 10.1089/met.2010.0068
- By:
- Publication type:
- Article
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified by National Cholesterol Education Program Risk Category
- Published in:
- Metabolic Syndrome & Related Disorders, 2009, v. 7, n. 6, p. 601, doi. 10.1089/met.2009.0009
- By:
- Publication type:
- Article
Consider old and new approaches when treating dyslipidaemia.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 10, p. 437, doi. 10.1007/s40267-022-00947-1
- By:
- Publication type:
- Article
Comparison of Evolocumab and Ezetimibe, Both Combined with Statin Therapy, for Patients with Recent Acute Coronary Syndrome: A Cost-Effectiveness Analysis from the Chinese Healthcare Perspective.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 905, doi. 10.1007/s10557-021-07276-x
- By:
- Publication type:
- Article
Effect of PCSK9 Monoclonal Antibody Versus Placebo/Ezetimibe on Atrial Fibrillation in Patients at High Cardiovascular Risk: A Meta-Analysis of 26 Randomized Controlled Trials.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 927, doi. 10.1007/s10557-022-07338-8
- By:
- Publication type:
- Article
Moderate-Intensity Statins Plus Ezetimibe vs. High-Intensity Statins After Coronary Revascularization: A Cohort Study.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 1, p. 141, doi. 10.1007/s10557-021-07256-1
- By:
- Publication type:
- Article
LDL Cholesterol Reduction Variability with Different Types and Doses of Statins in Monotherapy or Combined with Ezetimibe. Results from the Spanish Arteriosclerosis Society Dyslipidaemia Registry.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 2, p. 301, doi. 10.1007/s10557-020-07137-z
- By:
- Publication type:
- Article
Effects of atorvastatin and ezetimibe on endothelial function in dyslipidemic patients with chronic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 5, p. 704, doi. 10.1007/s10157-013-0904-7
- By:
- Publication type:
- Article
Lowering of Blood Lipid Levels with a Combination of Pitavastatin and Ezetimibe in Patients with Coronary Heart Disease: A Meta-Analysis.
- Published in:
- Cardiovascular Innovations & Applications (CVIA), 2022, v. 7, n. 1, p. 1, doi. 10.15212/CVIA.2023.0004
- By:
- Publication type:
- Article
Burkholderia cenocepacia: a new biocatalyst for efficient bioreduction of ezetimibe intermediate.
- Published in:
- Journal of Industrial Microbiology & Biotechnology, 2009, v. 36, n. 11, p. 1369, doi. 10.1007/s10295-009-0622-z
- By:
- Publication type:
- Article
Optimization of a gas chromatography{mass spectrometry method using chemometric techniques for the determination of ezetimibe in human plasma.
- Published in:
- Turkish Journal of Chemistry, 2013, v. 37, n. 5, p. 734, doi. 10.3906/kim-1210-18
- By:
- Publication type:
- Article
Lipid management -- Part 3: Triglycerides and use of non-statin drugs.
- Published in:
- Diabetes & Primary Care, 2024, v. 26, n. 4, p. 119
- By:
- Publication type:
- Article
Newer lipid-lowering therapies in type 2 diabetes.
- Published in:
- Diabetes & Primary Care, 2023, v. 25, n. 5, p. 161
- By:
- Publication type:
- Article
The management of lipids in diabetes: the key studies.
- Published in:
- Diabetes & Primary Care, 2019, v. 21, n. 1, p. 23
- By:
- Publication type:
- Article
Effect of phospholipid-polymer conjugate on physical properties of Rosuvastatin/Ezetimibe loaded lipid-polymer hybrid nanoparticles.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2023, v. 69, p. 77, doi. 10.33320/maced.pharm.bull.2023.69.03.038
- By:
- Publication type:
- Article
Influence of organic to aqueous phase solvent volume ratio on the physicochemical characteristics of rosuvastatin and ezetimibe loaded lipid-polymer hybrid nanoparticles prepared by nanoprecipitation method.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2022, v. 68, p. 305, doi. 10.33320/maced.pharm.bull.2022.68.03.147
- By:
- Publication type:
- Article
Niemann-Pick C1-Like 1 protein: Another target for treatment of dyslipidemia? Evidence from the Myocardial Infarction Genetic Consortium and IMPROVE-IT trials.
- Published in:
- Global Cardiology Science & Practice, 2014, v. 2014, n. 4, p. 179, doi. 10.5339/gcsp.2014.48
- By:
- Publication type:
- Article
In silico comparative analysis of cestode and human NPC1 provides insights for ezetimibe repurposing to visceral cestodiases treatment.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-72136-1
- By:
- Publication type:
- Article
Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Preparation and characterization of amorphous ezetimibe nanosuspensions intended for enhancement of oral bioavailability.
- Published in:
- International Journal of Pharmaceutical Investigation, 2014, v. 4, n. 3, p. 131, doi. 10.4103/2230-973X.138344
- By:
- Publication type:
- Article
A RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ATROVASTATIN AND EZETIMIBE IN PHARMACEUTICAL FORMULATION.
- Published in:
- Pharma Science Monitor, 2012, v. 3, n. 4, p. 1875
- By:
- Publication type:
- Article
Ezetimibe combined with standard diet and exercise therapy improves insulin resistance and atherosclerotic markers in patients with metabolic syndrome.
- Published in:
- Journal of Diabetes Investigation, 2015, v. 6, n. 3, p. 325, doi. 10.1111/jdi.12298
- By:
- Publication type:
- Article
Ezetimibe improves glucose metabolism by ameliorating hepatic function in Japanese patients with type 2 diabetes.
- Published in:
- Journal of Diabetes Investigation, 2012, v. 3, n. 2, p. 179, doi. 10.1111/j.2040-1124.2011.00147.x
- By:
- Publication type:
- Article
Effects of Statin versus the Combination of Ezetimibe plus Statin on Serum Lipid Absorption Markers in Patients with Acute Coronary Syndrome.
- Published in:
- Journal of Lipids, 2015, v. 2015, p. 1, doi. 10.1155/2015/109158
- By:
- Publication type:
- Article
Ezetimibe: Its Novel Effects on the Prevention and the Treatment of Cholesterol Gallstones and Nonalcoholic Fatty Liver Disease.
- Published in:
- Journal of Lipids, 2012, p. 1, doi. 10.1155/2012/302847
- By:
- Publication type:
- Article
Paraoxonase Activity and Expression Is Modulated by Therapeutics in Experimental Rat Nonalcoholic Fatty Liver Disease.
- Published in:
- International Journal of Hepatology, 2012, p. 1, doi. 10.1155/2012/265305
- By:
- Publication type:
- Article
Synergistic effect of simvastatin and ezetimibe on lipid and pro-inflammatory profiles in pre-diabetic subjects.
- Published in:
- Diabetology & Metabolic Syndrome, 2010, v. 2, n. 1, p. 1, doi. 10.1186/1758-5996-2-34
- By:
- Publication type:
- Article
Comparison between High-Dose Pitavastatin and Moderate-Dose Pitavastatin combined with Ezetimibe on LDL-C Levels in Type II Diabetics..
- Published in:
- Professional Medical Journal, 2023, v. 30, n. 8, p. 1021, doi. 10.29309/TPMJ/2023.30.08.7449
- By:
- Publication type:
- Article
Ezetimibe Prescribing Fails to Keep Up With Evidence.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 311, n. 13, p. 1279, doi. 10.1001/jama.2014.2896
- By:
- Publication type:
- Article
Lipid-Modifying Therapies and Risk of Pancreatitis: A Meta-analysis.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 308, n. 8, p. 804, doi. 10.1001/jama.2012.8439
- By:
- Publication type:
- Article
Cholesterol Drug Lowers LDL-C Levels But Again Fails to Show Clinical Benefit.
- Published in:
- JAMA: Journal of the American Medical Association, 2010, v. 303, n. 3, p. 211, doi. 10.1001/jama.2009.1915
- By:
- Publication type:
- Article
In ASCVD, moderate-intensity statin + ezetimibe was noninferior to high-intensity statin alone at 3 y.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Recommendations for use of ezetimibe and/or PCSK9 inhibitors in patients with elevated LDL-C.
- Published in:
- Annals of Internal Medicine, 2022, v. 175, n. 8, p. JC86, doi. 10.7326/J22-0060
- By:
- Publication type:
- Article
Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial.
- Published in:
- BMC Research Notes, 2012, v. 5, n. 1, p. 251, doi. 10.1186/1756-0500-5-251
- Publication type:
- Article
The Current Status for Management of Dyslipidemia in Elderly High-Risk Patients in Taiwan: A Real-World Data in a Tertiary Medical Center.
- Published in:
- International Journal of Gerontology, 2022, v. 16, n. 3, p. 247, doi. 10.6890/IJGE.202207_16(3).0015
- By:
- Publication type:
- Article
Drugs for hypercholesterolaemia - from statins to pro-protein convertase subtilisin kexin 9 (PCSK9) inhibition.
- Published in:
- Clinical Medicine, 2016, v. 16, n. 4, p. 353, doi. 10.7861/clinmedicine.16-4-353
- By:
- Publication type:
- Article
Effects of Ezetimibe, Simvastatin, and their Combination on Inflammatory Parameters in a Rat Model of Adjuvant-Induced Arthritis.
- Published in:
- Inflammation, 2017, v. 40, n. 2, p. 717, doi. 10.1007/s10753-016-0497-x
- By:
- Publication type:
- Article
Effects of Simvastatin, Ezetimibe, and Their Combination on Histopathologic Alterations Caused by Adjuvant-Induced Arthritis.
- Published in:
- Inflammation, 2014, v. 37, n. 4, p. 1035, doi. 10.1007/s10753-014-9826-0
- By:
- Publication type:
- Article
Effects of simvastatin and ezetimibe on interleukin-6 and high-sensitivity C-reactive protein.
- Published in:
- Scandinavian Cardiovascular Journal, 2013, v. 47, n. 1, p. 20, doi. 10.3109/14017431.2012.734635
- By:
- Publication type:
- Article
Trial confirms ‘lower is better’ for LDL cholesterol.
- Published in:
- British Journal of Hospital Medicine (17508460), 2014, v. 75, n. 12, p. 670
- By:
- Publication type:
- Article
Landmark data from SHARP show substantial benefits from reducing cholesterol in patients with chronic kidney disease.
- Published in:
- British Journal of Hospital Medicine (17508460), 2011, v. 72, n. 2, p. 71
- By:
- Publication type:
- Article
Lipid‐lowering treatment among older patients with atherosclerotic cardiovascular disease.
- Published in:
- Journal of the American Geriatrics Society, 2023, v. 71, n. 4, p. 1243, doi. 10.1111/jgs.18172
- By:
- Publication type:
- Article
Effect of Extended-Release Niacin on New-Onset Diabetes Among Hyperlipidemic Patients Treated With Ezetimibe/Simvastatin in a Randomized Controlled Trial.
- Published in:
- Diabetes Care, 2012, v. 35, n. 4, p. 857, doi. 10.2337/dc11-1369
- By:
- Publication type:
- Article
Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2010, v. 33, n. 9, p. 1954, doi. 10.2337/dc10-0320
- By:
- Publication type:
- Article
Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet.
- Published in:
- Diabetes Care, 2010, v. 33, n. 5, p. 1134, doi. 10.2337/dc09-1765
- By:
- Publication type:
- Article
Relationships Between Metabolic Syndrome and Other Baseline Factors and the Efficacy of Ezetimibe/Simvastatin and Atorvastatin in Patients With Type 2 Diabetes and Hypercholesterolemia.
- Published in:
- Diabetes Care, 2010, v. 33, n. 5, p. 1021, doi. 10.2337/dc09-1762
- By:
- Publication type:
- Article
Hypertension and Diabetes: Should We Treat Early Surrogates?
- Published in:
- Diabetes Care, 2009, v. 32, p. S290, doi. 10.2337/dc09-S329
- By:
- Publication type:
- Article
Lipoproteina(a) -- niezależny czynnik ryzyka sercowo-naczyniowego.
- Published in:
- Polish Heart Journal / Kardiologia Polska, 2024, v. 82, p. 212
- By:
- Publication type:
- Article